RESUMEN
Therapeutic vaccination of tumor patients with cytokine gene-transfected tumor cells leads to tumor regression in animal models but has so far not resulted in significant clinical benefit. We and others demonstrated that tumor cells transfected to mediate overexpression of a cytokine gene activate immunologic effector cells for an improved proliferation rate and significantly higher antitumoral cytotoxic activity. Here, we performed a pilot study of therapeutic vaccination in patients with metastatic disease. Autologous tumor cells were simultaneously transfected with novel minimalistic, immunogenically defined, gene expression constructs (MIDGE) for overexpression of the two cytokines interleukin 7 (IL-7) and GM-CSF and newly designed double stem-loop immunomodulating oligodeoxyribonucleotides (d-SLIM) as a Th1-promoting and NK cell-stimulating adjuvant. Transfection was performed ex vivo by ballistomagnetic gene transfer. Patients received four subcutaneous injections of at least 1 x 10(6) of their expression-modulated and immunomodified autologous tumor cells. Ten patients have been enrolled in the study protocol. In all patients no adverse effects could be detected. IL-7 and interferon gamma levels were elevated in the serum of the patients after treatment. Interestingly, cytotoxicity of patient-derived PBLs increased significantly during treatment. All 10 patients had progressive disease when entering our protocol. One complete, one partial, and one mixed response with progression of abdominal metastases and regression of lung metastases were observed. Two patients showed a stable disease after treatment and five patients remained in progressive disease. Our observations confirm the capability of autologous expression-modified and immunomodulated tumor cell vaccines to stimulate a strong immune response in patients with metastatic cancer even in the presence of a large tumor burden.
Asunto(s)
Vacunas contra el Cáncer , Carcinoma de Células Renales/terapia , Neoplasias del Colon/terapia , Técnicas de Transferencia de Gen , Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Interleucina-7/genética , Neoplasias Renales/terapia , Melanoma/terapia , Anciano , Complejo CD3/metabolismo , Antígeno CD56/metabolismo , Antígenos CD8/metabolismo , Carcinoma de Células Renales/patología , División Celular , Citocinas/genética , ADN/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Vectores Genéticos , Humanos , Hipersensibilidad Tardía , Interferón gamma/biosíntesis , Interleucina-7/biosíntesis , Neoplasias Renales/patología , Células Asesinas Naturales/metabolismo , Leucocitos Mononucleares/metabolismo , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Metástasis de la Neoplasia , Oligonucleótidos/metabolismo , Células TH1/metabolismo , Factores de Tiempo , Transfección , Resultado del TratamientoRESUMEN
Efficient gene transfer of lymphocytes is extremely difficult. We have shown previously that induction of apoptosis may play a role in the gene transfer resistance of lymphocytes. Anti-CD3 antibody can be used as a surrogate for receptor-mediated gene transfer in T lymphocytes. However, anti-CD3 antibody has been shown to be the causative agent of apoptosis in receptor-mediated gene transfer. In this study, we show that blockage of apoptosis by addition of low-dose cyclosporine A can lead to normalization of elevated TNF-alpha secretion and to a significant increase in the proliferation rate of transfected lymphocytes. In contrast, this had no negative effect on cytotoxic activity of immunologic effector cells called cytokine-induced killer cells. Therefore, blockage of apoptosis should have an impact on the use of lymphocytes transfected with cytokine genes as immunologic effector cells in cancer gene therapy protocols.
Asunto(s)
Apoptosis/efectos de los fármacos , Ciclosporina/uso terapéutico , Técnicas de Transferencia de Gen , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Complejo CD3/inmunología , División Celular , Células Cultivadas , Radioisótopos de Cromo/metabolismo , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Terapia Genética/métodos , Humanos , Inmunosupresores/uso terapéutico , Células Asesinas Naturales/metabolismo , Linfocitos/metabolismo , Plásmidos/metabolismo , TransfecciónRESUMEN
Melanoma primary cultures were transiently transfected via electroporation and lipofection for comparison. Transfection efficiency was superior with electroporation (58+/-9%) as compared to lipofection (23+/-9%) as determined by enhanced green fluorescent plasmid (EGFP) transfection. Secretion of IL-2 persisted for up to 3 weeks after electroporation. The increase in sensitivity against immunologic effector cells by transfection with IL-2 was not significant. Our results show the feasibility of a gene transfer into primary human melanoma cells, different from retroviral transduction.
Asunto(s)
Genes Reporteros , Interleucina-2/genética , Melanoma , Transfección/métodos , Antígenos CD/análisis , Resinas de Intercambio de Catión , Portadores de Fármacos , Electroporación/métodos , Proteínas Fluorescentes Verdes , Humanos , Inmunofenotipificación , Interleucina-2/análisis , Lípidos , Proteínas Luminiscentes/análisis , Proteínas Luminiscentes/genética , Proteínas Recombinantes/análisis , Proteínas Recombinantes/biosíntesis , Células Tumorales CultivadasRESUMEN
Patients with metastatic renal and colon carcinoma have a very poor prognosis. In many cases, the tumor recurs after surgical excision and chemotherapy. Therefore, it might be beneficial for cancer patients to induce an immune attack against the tumor by inserting a cytokine gene into the tumor cells. Here, two different techniques for isolation of single tumor cells were compared. An enzymatic solution was superior to an EDTA/DTT isolation solution for establishing tumor primary cultures. In total, 18 primary cell cultures could be established from 68 patients with colon and renal cell carcinoma. Cells were further characterized concerning fibroblast contamination, cell proliferation and HLA-typing. These primary tumor cells might be of value for cytokine gene transfer and in vaccination protocols for cancer patients.
Asunto(s)
Adenocarcinoma/patología , Carcinoma de Células Renales/patología , Neoplasias del Colon/patología , Neoplasias Renales/patología , Adenocarcinoma/inmunología , Antígenos de Neoplasias/análisis , Carcinoma de Células Renales/inmunología , Técnicas de Cultivo de Célula/métodos , División Celular , Separación Celular/métodos , Células Clonales/patología , Neoplasias del Colon/inmunología , Citocinas/genética , Electroporación , Antígenos HLA/análisis , Humanos , Queratinas/análisis , Neoplasias Renales/inmunología , Metástasis de la Neoplasia , Proteínas Recombinantes de Fusión/genética , Transfección , Células Tumorales Cultivadas/patologíaRESUMEN
Efficient gene transfer of lymphocytes is extremely difficult. Apoptosis may play a role in this gene transfer resistance of lymphocytes. Here we show that transfection of lymphocytes via non-viral vectors leads to induction of apoptosis in a significant proportion of cells. Since apoptosis may be mediated via tumor necrosis factor d (TNF-alpha) and the TNF-alpha receptor pathway, we studied the amount of TNF-alpha secreted by lymphocytes transfected without gene insert. TNF-alpha secretion was dependent on the gene transfer method used. High amounts were detected using receptor-mediated gene transfer and lipofection. In contrast, only low amounts of TNF-alpha were detected after electroporation and retroviral gene transfer. In receptor-mediated gene transfer, TNF-alpha secretion was due to the use of anti-CD3 antibody. Transfection of lymphocytes led to selective decrease in CD120b/TNF-alpha receptor II (TNFR-2)-positive cells. Induction of apoptosis and necrosis mediated by TNF-alpha via TNFR-2 (p80) was partially blocked using a neutralizing anti-TNF-alpha antibody. Blockage of apoptosis and necrosis could be further increased by adding anti-Fas-ligand (FasL) antibody, suggesting that induction of apoptosis via FasL and Fas receptor (Apo-1/CD95) may also play a role. This blockage led to a significant increase in the proliferation rate of lymphocytes transfected with cytokine genes. In conclusion, various gene transfer techniques led to TNF-alpha secretion, apoptosis and necrosis of lymphocytes. Apoptosis and necrosis could be partially blocked using a neutralizing anti-TNF-alpha antibody.